Mediclinic International plc

LSE:MDC Rapporto sulle azioni

Cap. di mercato: UK£3.7b

Mediclinic International Crescita futura

Future criteri di controllo 2/6

Mediclinic International prevede che gli utili e i ricavi cresceranno rispettivamente di 10.7% e 3.6% all'anno. Si prevede che l'EPS crescerà di 12.2% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 6.6% in 3 anni.

Informazioni chiave

10.7%

Tasso di crescita degli utili

12.2%

Tasso di crescita dell'EPS

Healthcare crescita degli utili23.1%
Tasso di crescita dei ricavi3.6%
Rendimento futuro del capitale proprio6.6%
Copertura analitica

Good

Ultimo aggiornamento30 May 2023

Aggiornamenti recenti sulla crescita futura

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Feb 11
Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Recent updates

Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Jul 26
Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)

Jul 12
Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Jun 28
Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?

Apr 08
Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Mar 09
Is Mediclinic International (LON:MDC) Using Too Much Debt?

Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt

Nov 20
Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Sep 08
Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Jun 21
Is Mediclinic International (LON:MDC) Using Too Much Debt?

Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

May 26
Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

Mar 17
If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Feb 26
What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Feb 11
Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Jan 27
Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

Jan 18
Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

Jan 01
These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

A Look At Mediclinic International's (LON:MDC) Share Price Returns

Dec 17
A Look At Mediclinic International's (LON:MDC) Share Price Returns

Our View On Mediclinic International's (LON:MDC) CEO Pay

Dec 02
Our View On Mediclinic International's (LON:MDC) CEO Pay

Previsioni di crescita degli utili e dei ricavi

LSE:MDC - Stime future degli analisti e dati finanziari passati (GBP Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/20263,888271N/AN/A1
3/31/20253,6842553305516
3/31/20243,5642373095256
3/31/20233,4412121834226
9/30/20223,383169283470N/A
6/30/20223,308160329512N/A
3/31/20223,233151375554N/A
12/31/20213,199135321483N/A
9/30/20213,165118266412N/A
6/30/20213,08093183324N/A
3/31/20212,9956899235N/A
12/31/20202,987-173N/AN/AN/A
9/30/20202,979-414133306N/A
6/30/20203,031-367203381N/A
3/31/20203,083-320273456N/A
12/31/20193,070-97N/AN/AN/A
9/30/20193,057126246443N/A
6/30/20192,995-12175394N/A
3/31/20192,932-151104344N/A
12/31/20182,897-380N/AN/AN/A
9/30/20182,861-61023277N/A
6/30/20182,869-55157311N/A
3/31/20182,876-49291345N/A
12/31/20172,874-211N/AN/AN/A
9/30/20172,8716997350N/A
6/30/20172,810149121364N/A
3/31/20172,749229145377N/A
12/31/20162,565210155375N/A
9/30/20162,380191165373N/A
6/30/20162,244184N/A347N/A
3/31/20162,107177N/A320N/A
12/31/20152,080211N/A314N/A
9/30/20152,183257N/A330N/A
6/30/20152,042245N/A327N/A
3/31/20151,977241N/A337N/A
12/31/20141,901221N/A312N/A
9/30/20141,810199N/A284N/A
6/30/20141,751193N/A270N/A
3/31/20141,738193N/A263N/A
12/31/20131,65282N/A253N/A
9/30/20131,653-33N/A257N/A
6/30/20131,701-55N/A256N/A
3/31/20131,742-79N/A253N/A
12/31/20121,72919N/A232N/A
9/30/20121,730118N/A213N/A
6/30/20121,759109N/A198N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di MDC ( 10.7% all'anno) è superiore al tasso di risparmio ( 1.2% ).

Guadagni vs Mercato: Si prevede che gli utili di MDC ( 10.7% all'anno) cresceranno più rapidamente del mercato UK ( 14.3% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di MDC cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di MDC ( 3.6% all'anno) crescerà più lentamente rispetto al mercato UK ( 3.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di MDC ( 3.6% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di MDC sarà basso tra 3 anni ( 6.6 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y